Engineering Vascularized Cardiac Muscle
工程血管化心肌
基本信息
- 批准号:7900656
- 负责人:
- 金额:$ 0.93万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-07-01 至 2013-04-16
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant):
Our current inability to vascularize and perfuse thick cell masses has hindered efforts to engineer many types of functional tissues including, most critically, cardiac muscle. To serve as a graft for myocardial repair, an engineered cardiac construct must be thick and compact, contain physiologic density of differentiated cells, and contract synchronously in response to electrical stimulation. In addition, the graft must have a capability to integrate with the host vasculature in order to maintain the viability and function of transplanted cells. We propose to engineer functional vascularized myocardium by integrating and advancing our ongoing efforts in the areas of cardiac tissue engineering (MIT) and vascular tissue engineering (Duke). We hypothesize that the cultivation of cardiac myocytes and endothelial cells on specialized scaffolds (highly porous, biodegradable, elastic, with an array of channels) in a bioreactor with medium perfusion and electrical stimulation will promote functional assembly of synchronously contractile engineered muscle. We further hypothesize that vascularization in vitro will enhance the graft capacity for survival, integration and function in vivo. In order to test these hypotheses, which have been derived from two lines of our previous investigations, we propose studies with the following Specific Aims: (1) High density culture of cardiac myocytes on channeled scaffolds with medium perfusion and electrical stimulation, (2) Tissue engineering of a vascularized network, and (3) Tissue engineering and functional characterization of a vascularized cardiac muscle. The effects of perfusion and electrical stimulation on the progression of endothelial cell and myocyte assembly into a synchronously contractile myocardium will be studied in vitro and in vivo (implantation onto a left ventricle in an adult rat model of infarction). Tissue structure and function will be characterized at various hierarchical scales (molecular, structural, functional) and the obtained experimental and modeling data will be used to tailor the conditions and duration of cultivation and engineer implantable grafts. As such, the current proposal is a blueprint for the generation of vascularized cardiac muscle suitable for implantation into injured myocardium.
描述(由申请人提供):
我们目前无法进行血管化和灌注厚的细胞肿块,阻碍了努力,以设计许多类型的功能组织,包括心脏肌肉。为了作为心肌修复的移植物,工程的心脏构建体必须厚而紧凑,包含分化细胞的生理密度,并响应于电刺激而同步收缩。此外,移植物必须具有与宿主脉管系统整合的能力,以维持移植细胞的生存能力和功能。我们建议通过整合和推进我们在心脏组织工程(MIT)和血管组织工程(DUKE)领域的持续努力来设计功能性血管化心肌。我们假设在具有中等灌注和电刺激的生物反应器中,在专门的脚手架(高度多孔,可生物降解,具有一系列通道的弹性)上培养心肌细胞和内皮细胞,将促进同步收缩工程的肌肉的功能组装。我们进一步假设体外血管化将增强体内生存,整合和功能的移植能力。为了测试这些假设,这些假设源自我们先前研究的两行,我们提出了以下特定目的的研究:(1)具有中等灌注和电刺激的通道支架上的心肌细胞的高密度培养,(2)血管性网络的组织工程,以及(3)组织工程和功能性的carsifatient Card Cards carcartic carcartic Card Cardcormity carcartic sasciact of Cast sasciact of Card sasciact of Card sasciact of Cars sous carcular sasciact of Cars sasciact of Cars sous carcultiac sasciact ass sasciact of Cast sasciact。将在体外和体内研究灌注和电刺激对内皮细胞和心肌组件进展为同步收缩的心肌的影响(植入成人梗死大鼠模型中的左心室)。组织结构和功能将在各种层次尺度(分子,结构,功能)下进行表征,并且获得的实验和建模数据将用于量身定制培养的条件和持续时间以及工程师的植入植物。因此,当前的建议是生成适合植入受伤心肌的血管肌肉的蓝图。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Gordana Vunjak-No...的其他基金
Tissue Engineering Resource Center-Treatment of COVID-19 induced acute respiratory distress by inhalation of exosomes
组织工程资源中心-吸入外泌体治疗COVID-19引起的急性呼吸窘迫
- 批准号:1016417910164179
- 财政年份:2020
- 资助金额:$ 0.93万$ 0.93万
- 项目类别:
相似国自然基金
促细胞外囊泡分泌的绒毛膜纳米纤维仿生培养体系的构建及其在宫腔粘连修复中的应用研究
- 批准号:32301204
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
载Pexidartinib的纳米纤维膜通过阻断CSF-1/CSF-1R通路抑制巨噬细胞活性预防心脏术后粘连的研究
- 批准号:82370515
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
泛素连接酶SMURF2通过SMAD6-COL5A2轴调控宫腔粘连纤维化的分子机制研究
- 批准号:82360301
- 批准年份:2023
- 资助金额:31 万元
- 项目类别:地区科学基金项目
负载羟基喜树碱的双层静电纺纳米纤维膜抑制肌腱粘连组织增生的作用和相关机制研究
- 批准号:82302691
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
膜仿生载基因纳米球体内重编程巨噬细胞抑制肌腱粘连的机制研究
- 批准号:82372389
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Dissecting the role of the cardiac fibroblast in hypertrophy.
剖析心脏成纤维细胞在肥厚中的作用。
- 批准号:1066759510667595
- 财政年份:2022
- 资助金额:$ 0.93万$ 0.93万
- 项目类别:
Dissecting the role of the cardiac fibroblast in hypertrophy.
剖析心脏成纤维细胞在肥厚中的作用。
- 批准号:1051402810514028
- 财政年份:2022
- 资助金额:$ 0.93万$ 0.93万
- 项目类别:
A Novel Role for cMyc in Vascular Homeostasis
cMyc 在血管稳态中的新作用
- 批准号:1015971610159716
- 财政年份:2020
- 资助金额:$ 0.93万$ 0.93万
- 项目类别:
A Novel Role for cMyc in Vascular Homeostasis
cMyc 在血管稳态中的新作用
- 批准号:93834919383491
- 财政年份:2017
- 资助金额:$ 0.93万$ 0.93万
- 项目类别: